DK0719328T3 - Genet GRB 3-3, varianter deraf og anvendelse deraf - Google Patents

Genet GRB 3-3, varianter deraf og anvendelse deraf

Info

Publication number
DK0719328T3
DK0719328T3 DK94915598T DK94915598T DK0719328T3 DK 0719328 T3 DK0719328 T3 DK 0719328T3 DK 94915598 T DK94915598 T DK 94915598T DK 94915598 T DK94915598 T DK 94915598T DK 0719328 T3 DK0719328 T3 DK 0719328T3
Authority
DK
Denmark
Prior art keywords
variants
grb
genet
protein
sequences
Prior art date
Application number
DK94915598T
Other languages
Danish (da)
English (en)
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0719328T3 publication Critical patent/DK0719328T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK94915598T 1993-09-15 1994-05-09 Genet GRB 3-3, varianter deraf og anvendelse deraf DK0719328T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9310971A FR2710074B1 (fr) 1993-09-15 1993-09-15 Gène GRB3-3, ses variants et leurs utilisations.
PCT/FR1994/000542 WO1995007981A1 (fr) 1993-09-15 1994-05-09 Gene grb3-3, ses variants et leurs utilisations

Publications (1)

Publication Number Publication Date
DK0719328T3 true DK0719328T3 (da) 2000-11-13

Family

ID=9450882

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94915598T DK0719328T3 (da) 1993-09-15 1994-05-09 Genet GRB 3-3, varianter deraf og anvendelse deraf

Country Status (27)

Country Link
US (2) US5831048A (fi)
EP (1) EP0719328B1 (fi)
JP (1) JP3794697B2 (fi)
KR (1) KR100330477B1 (fi)
CN (1) CN1098930C (fi)
AT (1) ATE196926T1 (fi)
AU (1) AU698819B2 (fi)
BR (1) BR9407693A (fi)
CA (1) CA2169938A1 (fi)
CZ (1) CZ288882B6 (fi)
DE (1) DE69426121T2 (fi)
DK (1) DK0719328T3 (fi)
ES (1) ES2152313T3 (fi)
FI (1) FI120499B (fi)
FR (1) FR2710074B1 (fi)
GR (1) GR3034600T3 (fi)
HU (1) HU221516B (fi)
IL (2) IL126756A (fi)
NO (1) NO319144B1 (fi)
NZ (1) NZ266162A (fi)
PL (1) PL178402B1 (fi)
PT (1) PT719328E (fi)
RU (1) RU2159815C2 (fi)
SK (1) SK281123B6 (fi)
UA (1) UA46715C2 (fi)
WO (1) WO1995007981A1 (fi)
ZA (1) ZA947059B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732348B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Systeme d'expression conditionnel
US6171800B1 (en) 1995-06-07 2001-01-09 Biogen, Inc. Method of making and binding CAIP polypeptides
US5837844A (en) * 1995-06-07 1998-11-17 Biogen, Inc. CAIP-like gene family
US6423824B1 (en) 1995-06-07 2002-07-23 Biogen, Inc. CAIP-like gene family
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
AU6342696A (en) * 1996-06-27 1998-01-14 Biogen, Inc. The caip-like gene family
US7309692B1 (en) 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) * 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
EP0998945A1 (en) * 1998-09-30 2000-05-10 Transgene S.A. Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
IL151928A0 (en) 2000-03-30 2003-04-10 Whitehead Biomedical Inst Rna sequence-specific mediators of rna interference
RU2322500C2 (ru) 2000-12-01 2008-04-20 Макс-Планк-Гезелльшафт Цур Фердерунг Дер Виссеншафтен Е.Ф. Малые молекулы рнк, опосредующие интерференцию рнк
US20040043950A1 (en) * 2002-01-03 2004-03-04 Board Of Regents, The University Of Texas System WT1 antisense oligos for the inhibition of breast cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE187772T1 (de) 1991-01-18 2000-01-15 Univ New York Cdns-klonierungsverfahren für rezeptortyrosinkinasezielprotein und hgrb- proteine
AU5136093A (en) * 1992-09-25 1994-04-26 Warner-Lambert Company Peptide antagonists of sh2 binding and therapeutic uses thereof

Also Published As

Publication number Publication date
PL313445A1 (en) 1996-07-08
DE69426121D1 (de) 2000-11-16
NO960965D0 (no) 1996-03-08
HU9600668D0 (en) 1996-05-28
CZ75896A3 (en) 1996-06-12
AU698819B2 (en) 1998-11-05
CZ288882B6 (cs) 2001-09-12
FI120499B (fi) 2009-11-13
PL178402B1 (pl) 2000-04-28
HUT74273A (en) 1996-11-28
GR3034600T3 (en) 2001-01-31
IL110942A (en) 2001-12-23
AU6724794A (en) 1995-04-03
NO319144B1 (no) 2005-06-27
ATE196926T1 (de) 2000-10-15
IL110942A0 (en) 1994-11-28
HU221516B (hu) 2002-11-28
KR100330477B1 (ko) 2002-12-02
RU2159815C2 (ru) 2000-11-27
CN1098930C (zh) 2003-01-15
IL126756A (en) 2006-06-11
EP0719328B1 (fr) 2000-10-11
ZA947059B (en) 1995-05-18
ES2152313T3 (es) 2001-02-01
US5831048A (en) 1998-11-03
JP3794697B2 (ja) 2006-07-05
PT719328E (pt) 2001-02-28
BR9407693A (pt) 1997-02-04
EP0719328A1 (fr) 1996-07-03
NO960965L (no) 1996-03-08
NZ266162A (en) 1997-11-24
JPH09502357A (ja) 1997-03-11
WO1995007981A1 (fr) 1995-03-23
FR2710074A1 (fr) 1995-03-24
FI961202A (fi) 1996-03-14
CA2169938A1 (fr) 1995-03-23
FR2710074B1 (fr) 1995-12-08
CN1133064A (zh) 1996-10-09
DE69426121T2 (de) 2001-05-31
USRE37952E1 (en) 2002-12-31
SK281123B6 (sk) 2000-12-11
UA46715C2 (uk) 2002-06-17
FI961202A0 (fi) 1996-03-14
SK34596A3 (en) 1996-07-03

Similar Documents

Publication Publication Date Title
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
DK0719328T3 (da) Genet GRB 3-3, varianter deraf og anvendelse deraf
ES2105698T3 (es) Oligonucleotidos modificados con 7-deazapurina.
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
DK1548032T3 (da) KDR-peptider og vacciner indeholdende disse
DK289688A (da) Ekspression af proapolipoprotein a-i.
DK0981630T3 (da) Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme
DK0640133T3 (da) Rekombinante DNA-molekyler, der koder for aminopeptidaseenzymer og deres anvendelse i fremstillingen af vacciner mod helmin
DE69535696D1 (de) Tripeptidyl-aminopeptidase
DK0793721T3 (da) Peptider, der er i stand til at binde sig til GAP-proteinets SH3-domæne, nukleotidsekvenser, der koder derfor, fremstilling og anvendelse deraf
IL110392A0 (en) 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
DE69321720D1 (de) Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
DK1005532T3 (da) Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf
PE20399A1 (es) Muteina ob
DK0788549T3 (da) Regulerende nukleinsyresekvenser og anvendelser
IT1256078B (it) Ligandi kit solubili
SE9901115D0 (sv) Nucleotide sequences